57 results
8-K
EX-10.1
i5ufnhf7x
28 Mar 24
CervoMed Announces Up to $149.4 Million Private Placement Financing Joined by Leading Healthcare Investors
8:36am
8-K/A
EX-99.2
mrggl1djg bt
29 Sep 23
Completion of Acquisition or Disposition of Assets
4:01pm
424B3
cmp1bm
13 Jul 23
Prospectus supplement
4:32pm
S-4/A
xqhhpya4x9h
22 Jun 23
Registration of securities issued in business combination transactions (amended)
9:46pm
S-4
3ljz03
10 May 23
Registration of securities issued in business combination transactions
9:56pm
8-K
EX-1.1
l9ceb8qfz hfmz
22 Jul 22
Entry into a Material Definitive Agreement
4:20pm
8-K
EX-99.1
3ajz27
23 May 22
Diffusion Pharmaceuticals Announces Appointment of Raven Jaeger, M.S., as Chief Regulatory Officer
5:42pm
8-K
EX-99.1
ms9y5l521ni8wdo
16 May 22
Diffusion Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Business Update
12:00am